170 results
Page 3 of 9
8-K
EX-1.1
gi9wtzqgxb815wclt
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
424B5
0finbu3
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
b0daunm xov467
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
uad01ij2tr4 j8
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
34sehd mvx5
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
igvnpa48 lq
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K/A
EX-99.1
47a65qex8 uiu1trypu
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-10.3
v9lww
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
dusfl mbnna
28 Aug 20
Prospectus supplement
4:31pm